Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a clinical trial registry record describing an active Phase 3 study with no results posted; the planned design is sound but efficacy and safety outcomes remain unreported.
This is a Phase 2 proof-of-concept study registration with no results reported; the trial is actively recruiting and designed to explore HER3-DXd monotherapy across multiple solid tumor types.
This is a clinical trial registry record for an expanded access program with no results posted; it describes a planned intervention pathway, not clinical evidence of efficacy or safety.
Phase 3 randomized trial of ifinatamab deruxtecan versus physician's choice in relapsed SCLC; registry record with no results posted, so efficacy and safety remain unreported.